These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?]. Lanas Arbeloa A; Serrano Aulló MT Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198 [No Abstract] [Full Text] [Related]
6. Prostaglandins in peptic ulceration. Fenn GC Br J Hosp Med; 1992 Dec 2-1993 Jan 5; 48(11):776. PubMed ID: 1361396 [No Abstract] [Full Text] [Related]
7. Current indications for acid suppressants in Helicobacter pylori -negative ulcer disease. Howden CW; Leontiadis GI Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):401-12. PubMed ID: 11403535 [TBL] [Abstract][Full Text] [Related]
8. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"]. Gorshkov VA Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232 [No Abstract] [Full Text] [Related]
9. [Effect of NSAIDs on gastric mucosal damage induced by H. pylori infection]. Iwakiri R; Fujimoto K Nihon Rinsho; 2002 Feb; 60 Suppl 2():222-6. PubMed ID: 11979782 [No Abstract] [Full Text] [Related]
10. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals. Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106 [TBL] [Abstract][Full Text] [Related]
11. [Inhibitory factors for healing of NSAIDs-induced ulcers]. Yanaka A Nihon Rinsho; 2002 Feb; 60 Suppl 2():559-61. PubMed ID: 11979845 [No Abstract] [Full Text] [Related]
12. [New therapeutic approaches to peptic ulcer using mucosal protective agents]. Jin M; Otaka M; Watanabe S Nihon Rinsho; 2002 Feb; 60 Suppl 2():377-81. PubMed ID: 11979810 [No Abstract] [Full Text] [Related]
14. Peptic ulcer disease in the elderly. Cryer B; Feldman M Semin Gastrointest Dis; 1994 Oct; 5(4):166-78. PubMed ID: 7834250 [No Abstract] [Full Text] [Related]
15. [Eradication of Helicobacter pylori and use of antisecretory drugs--a population based study]. Lassen AT; Hallas J; Schaffalitzky de Muckadell OB Ugeskr Laeger; 2004 Sep; 166(39):3405-7. PubMed ID: 15515395 [No Abstract] [Full Text] [Related]
16. The importance of addressing the condition of nonsteroidal anti-inflammatory drug-related gastropathy. Cryer B Am J Manag Care; 2001 Sep; 7(12 Suppl):S407-11. PubMed ID: 11570034 [No Abstract] [Full Text] [Related]
17. [Prostaglandins and damage to the gastric mucosa]. Varró V Orv Hetil; 1991 Jul; 132(27):1461-7. PubMed ID: 1683479 [TBL] [Abstract][Full Text] [Related]
18. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs. Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111 [TBL] [Abstract][Full Text] [Related]
19. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy. Lanas A; Remacha B; Sáinz R; Hirschowitz BI Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760 [TBL] [Abstract][Full Text] [Related]
20. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong. Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]